Mount Sinai Hospital, Chicago, IL
Paramjeet Khosla, Julia Rachel Trosman, James Gerhart, Urjeet Patel, Shelly S. Lo, Frank J. Penedo, Patricia A. Robinson, Aidnag Diaz, Teresa Lillis, Harry Miranda, Erika K. Radeke, Betty Roggenkamp, Mary Pasquinelli, Lawrence Eric Feldman, Joanna Martin, Sheetal Mehta Kircher, Sofia F. Garcia, Rosa Berardi, Christine B. Weldon
Background: The Institute of Medicine (IOM) 2013 Report recommends that supportive oncology care start at cancer diagnosis; the Commission on Cancer (CoC) Standard 3.2 requires distress screening and indicated action. Screening tools are not standardized and often address only a portion of patients’ supportive oncology needs. Methods: A collaborative of 100+ clinicians, funded by The Coleman Foundation, developed a patient-centric screening tool adapted from NCCN Distress Problem List, IOM report and CoC standards, with validated sub-tools: PHQ-4 for anxiety and depression and PROMIS short forms for pain, fatigue and physical function. Novel treatment/care and other concerns were included. The screening tool was implemented at 4 cancer centers (2 academic, 1 public & 1 safety-net). End points included correlation of PHQ-4 score with other supportive oncology needs. Descriptive statistics, Fisher’s exact test were used. Results: 2805 patients were screened. Average scores were: PHQ4 – Anxiety and Depression 1.8 (mild > 3), Pain 4.5 (mild > 4), Fatigue 8.8 (mild > 6), Physical Function 20.2 (mild < 20), see table for additional items. Higher scores on the PHQ-4 were significantly associated with each of the following: greater pain, fatigue, , nutritional and specific treatment/care concerns, and lower physical function (p<.0001). (See Table). Conclusions: Patients with higher anxiety and depression also have many other supportive oncology concerns. Our results support the use of a comprehensive tool capturing a spectrum of each patient’s unique concerns. This may enable earlier interventions and personalized delivery of supportive care.
Screening Item | Frequency n=2805 |
---|---|
I want to better understand my prognosis or long term outcome | 44% |
I want to better understand my cancer diagnosis or stage | 38% |
I have questions about my treatment options, medication, or my plan of care | 28% |
Sleep concerns | 28% |
Tingling in hands/feet | 24% |
Dry mouth | 21% |
Concerns about other family members | 19% |
Skin dry/itchy, blister/pain | 19% |
I feel peaceful (counted if No) | 19% |
Issues with taste | 19% |
I want help communicating my wishes for treatment | 18% |
I have a sense of purpose or meaning (counted if No) | 17% |
Constipation | 16% |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2017 ASCO Annual Meeting
First Author: Julia Rachel Trosman
2022 ASCO Annual Meeting
First Author: Andrea de la O Murillo
2019 Gastrointestinal Cancers Symposium
First Author: Amy Westermann
2022 ASCO Annual Meeting
First Author: Pooja N. Bhakta